# Strategies for Management of Recurrent Pterygium

> **NCT02530801** · PHASE4 · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 25 (estimated)

## Conditions studied

- Recurrent Pterygium

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** 5 fluorouracil

## Key facts

- **NCT ID:** NCT02530801
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-04
- **Final completion:** 2018-08
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530801, "Strategies for Management of Recurrent Pterygium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02530801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*